Chen, Jun

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine

Cell death mechanisms and regulationCancer-related Molecular Pathways

Cited by 3,058

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

Cheng, Y., Han, L., Wu, L., Chen, J., Sun, H., Wen, G., Ji, Y., Dvorkin, M., Shi, J., Pan, Z., et al. (2022) · JAMA

Lung Cancer Research StudiesCancer Immunotherapy and Biomarkers

Cited by 492

SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy

Veillette, A., & Chen, J. (2018) · Trends in Immunology

Phagocytosis and Immune RegulationCancer Immunotherapy and Biomarkers

Cited by 476

Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains

Shi, J.-Q., Shen, W., Chen, J., Wang, B.-R., Zhong, L.-L., Zhu, Y.-W., Zhu, H.-Q., Zhang, Q.-Q., Zhang, Y.-D., & Xu, J. (2011) · Brain Research

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 219

Contribution of p16 INK4a and p21 CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53

Chen, J., Huang, X., Halicka, D., Brodsky, S., Avram, A., Eskander, J., Bloomgarden, N. A., Darzynkiewicz, Z., & Goligorsky, M. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology

Telomeres, Telomerase, and SenescenceCancer-related Molecular Pathways

Cited by 142

Aberrant activation of the androgen receptor by NF-κB2/p52 in prostate cancer cells.

Nadiminty, N., Lou, W., Sun, M., Chen, J., Yue, J., Kung, H.-J., Evans, C. P., Zhou, Q., & Gao, A. C. (2010) · Cancer Research

Prostate Cancer Treatment and ResearchNF-κB Signaling Pathways

Cited by 113

Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment

Zhang, R., Ma, M., Lin, X.-H., Liu, H.-H., Chen, J., Chen, J., Gao, D.-M., Cui, J.-F., Ren, Z.-G., & Chen, R.-X. (2018) · BMC Cancer

Hepatocellular Carcinoma Treatment and PrognosisLiver physiology and pathology

Cited by 68

Tumor metabolic reprogramming in lung cancer progression (Review)

Li, X., Liu, M., Liu, H., & Chen, J. (2022) · Oncology Letters

Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

Cited by 52

Dynamics of Albumin Synthetic Response to Intra-Abdominal Abscess in Patients with Gastrointestinal Fistula

Zhou, B., Ren, J., Han, G., Chen, Y., A, J., Gu, G., Chen, J., Wang, G., & Li, J. (2014) · Surgical Infections

Abdominal Surgery and ComplicationsSepsis Diagnosis and Treatment

Cited by 7

Efficacy and safety of bevacizumab biosimilar SIBP04 compared with bevacizumab (Avastin®) as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lung cancer: A randomized, double-blind, phase 3 trial

Shi, Y., Bi, M., Li, Q., Wang, G., Chen, J., Li, M., Shi, J., Mei, J., Ji, Y., Xia, Q., et al. (2025) · Cancer Pathogenesis and Therapy

Lung Cancer Treatments and MutationsBiosimilars and Bioanalytical Methods

Cited by 2